TCBWF

TC Biopharm (Holdings) Plc

Price Chart

No historical data available

Latest Quote

$0.00

+0.00 (+6.67%)

Current Price

Previous Close	$0.00
Open	$0.00
Day High	$0.00
Day Low	$0.00
Volume	3,333

Fetched: 2026-06-05T17:32:08

Stock Information

Note: Financial values converted from GBP to USD

Total Debt	$2.01M
Cash Equivalents	$1.63M
Net Income	$-16.28M
Exchange	PNK

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About TC Biopharm (Holdings) Plc

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections, as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

📰 Latest News

No news articles available at the moment. Check back later for updates on TCBWF.

Period:

Income Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue
Total Revenue	$0	$0	$3,844,532	$1,978,659
Operating Revenue	$0	$0	$3,844,532	$1,978,659
Expenses
Interest Expense	$0	$83,025	$6,753,231	$3,438,548
Total Expenses	$12,767,670	$14,239,323	$15,928,529	$9,259,302
Other Income Expense	$-38,331	$7,326,666	$15,803,627	$-4,264,309
Other Non Operating Income Expenses	$-51,768	$-80,070	$-120,974	-
Net Non Operating Interest Income Expense	$0	$-83,025	$-6,753,231	$-3,438,515
Interest Expense Non Operating	$0	$83,025	$6,753,231	$3,438,548
Operating Expense	$12,767,670	$14,239,323	$15,928,529	$9,259,302
General And Administrative Expense	$7,400,624	$6,467,932	$8,336,059	$3,108,794
Other Operating Expenses	-	-	-	$-6,381
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-12,154,030	$-5,906,953	$-1,313,601	$-13,575,925
Net Interest Income	$0	$-83,025	$-6,753,231	$-3,438,515
Normalized Income	$-12,166,783	$-12,160,988	$-14,212,528	$-9,712,204
Net Income From Continuing And Discontinued Operation	$-12,154,030	$-5,906,953	$-1,313,601	$-13,575,925
Total Operating Income As Reported	$-12,767,670	$-14,239,323	$-12,083,997	-
Net Income Common Stockholders	$-12,154,030	$-5,906,953	$-1,313,601	$-13,575,925
Net Income	$-12,154,030	$-5,906,953	$-1,313,601	$-13,575,925
Net Income Including Noncontrolling Interests	$-12,154,030	$-5,906,953	$-1,313,601	$-13,575,925
Net Income Continuous Operations	$-12,154,030	$-5,906,953	$-1,313,601	$-13,575,925
Pretax Income	$-12,806,001	$-6,995,682	$-3,033,601	$-14,983,467
Special Income Charges	$0	$-645,845	$-140,344	$0
Operating Income	$-12,767,670	$-14,239,323	$-12,083,997	$-7,280,643
Interest Income	-	-	$2,208	$33
Interest Income Non Operating	-	-	$2,208	$33
Other
Tax Effect Of Unusual Items	$684	$1,152,701	$3,025,674	$-400,588
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-12,385,169	$-13,686,385	$-11,435,375	$-6,255,552
Total Unusual Items	$13,437	$7,406,736	$15,924,601	$-4,264,309
Total Unusual Items Excluding Goodwill	$13,437	$7,406,736	$15,924,601	$-4,264,309
Reconciled Depreciation	$434,269	$633,008	$769,596	$1,025,058
EBITDA (Bullshit earnings)	$-12,371,732	$-6,279,649	$4,489,226	$-10,519,861
EBIT	$-12,806,001	$-6,912,657	$3,719,630	$-11,544,919
Diluted NI Availto Com Stockholders	$-12,154,030	$-5,906,953	$-1,313,601	$-13,575,925
Tax Provision	$-651,971	$-1,088,729	$-1,720,000	$-1,407,542
Gain On Sale Of Security	$13,437	$8,052,581	$16,064,945	$-4,264,309
Research And Development	$5,367,046	$7,771,391	$7,592,470	$6,156,889
Selling General And Administration	$7,400,624	$6,467,932	$8,336,059	$3,108,794
Other Gand A	$7,400,624	$6,467,932	$8,336,059	$3,108,794
Other Special Charges	-	$645,845	$140,344	-

Fetched: 2026-02-02

Balance Sheet (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Net Tangible Assets	$2,543,361	$2,070,060	$-221,751	$-17,042,626
Total Assets	$8,328,537	$8,931,664	$11,291,977	$8,023,596
Total Non Current Assets	$2,553,886	$3,230,737	$3,844,461	$4,167,756
Goodwill And Other Intangible Assets	$466,262	$615,170	$553,016	$483,577
Other Intangible Assets	$466,262	$615,170	$553,016	$483,577
Current Assets	$5,774,651	$5,700,927	$7,447,516	$3,855,840
Current Deferred Assets	$3,031,989	$1,177,500	$0	-
Prepaid Assets	$786,803	$829,999	$836,137	$811,303
Receivables	$740,219	$1,230,819	$1,803,319	$1,477,849
Other Receivables	$7,837	$51,584	$56,264	-
Taxes Receivable	$732,382	$1,179,235	$1,747,055	$1,477,849
Cash Cash Equivalents And Short Term Investments	$1,215,640	$2,462,609	$4,808,060	$1,566,688
Cash And Cash Equivalents	$1,215,640	$2,462,609	$4,808,060	$1,566,688
Debt
Total Debt	$1,499,483	$1,801,157	$2,778,352	$9,708,843
Long Term Debt And Capital Lease Obligation	$1,171,019	$1,495,833	$1,796,835	$2,136,875
Current Debt And Capital Lease Obligation	$328,464	$305,324	$981,517	$7,571,968
Current Debt	-	-	$653,484	$6,806,210
Other Current Borrowings	-	-	$653,484	$6,806,210
Net Debt	-	-	-	$5,239,522
Liabilities
Total Liabilities Net Minority Interest	$5,318,914	$6,246,434	$10,960,712	$24,582,645
Total Non Current Liabilities Net Minority Interest	$1,171,019	$1,495,833	$1,796,835	$4,002,748
Current Liabilities	$4,147,895	$4,750,601	$9,163,877	$20,579,897
Payables And Accrued Expenses	$3,819,431	$4,431,840	$2,159,058	$4,103,615
Payables	$1,629,988	$2,024,921	$1,214,154	$1,773,033
Other Payable	$488	$38,613	$38,323	$39,436
Total Tax Payable	$236,175	$139,029	$293,467	$311,204
Accounts Payable	$1,393,325	$1,847,279	$882,364	$1,422,393
Other Current Liabilities	-	$13,437	$6,023,302	$6,925,654
Non Current Deferred Liabilities	-	-	$0	$1,865,873
Current Deferred Liabilities	-	-	$0	$1,978,660
Equity
Common Stock Equity	$3,009,623	$2,685,230	$331,265	$-16,559,049
Total Equity Gross Minority Interest	$3,009,623	$2,685,230	$331,265	$-16,559,049
Stockholders Equity	$3,009,623	$2,685,230	$331,265	$-16,559,049
Other Equity Interest	$397,398	$397,398	$397,398	-
Retained Earnings	$-52,559,029	$-40,404,999	$-33,374,796	$-33,465,282
Gains Losses Not Affecting Retained Earnings	-	-	$16,710,757	$16,710,757
Other Equity Adjustments	-	-	$16,710,757	$16,710,757
Other
Ordinary Shares Number	$2,489,348,051	$25,712,610	$2,181,141	$488,690
Share Issued	$2,489,348,051	$25,712,610	$2,181,141	$488,690
Tangible Book Value	$2,543,361	$2,070,060	$-221,751	$-17,042,626
Invested Capital	$3,009,623	$2,685,230	$984,749	$-9,752,839
Working Capital	$1,626,756	$950,326	$-1,716,361	$-16,724,057
Capital Lease Obligations	$1,499,483	$1,801,157	$2,124,868	$2,902,633
Total Capitalization	$3,009,623	$2,685,230	$331,265	$-16,559,049
Additional Paid In Capital	$54,916,172	$42,690,774	$33,308,568	$0
Capital Stock	$255,082	$2,057	$95	$195,476
Common Stock	$255,082	$2,057	$95	$195,476
Long Term Capital Lease Obligation	$1,171,019	$1,495,833	$1,796,835	$2,136,875
Current Capital Lease Obligation	$328,464	$305,324	$328,033	$765,758
Current Accrued Expenses	$2,189,443	$2,406,919	$944,904	$2,330,582
Net PPE	$2,087,624	$2,615,567	$3,291,445	$3,684,179
Accumulated Depreciation	$-4,540,969	$-4,157,382	$-3,560,656	$-3,010,486
Gross PPE	$6,628,593	$6,772,949	$6,852,101	$6,694,665
Machinery Furniture Equipment	$5,495,777	$5,432,180	$5,321,827	$5,309,141
Buildings And Improvements	$1,132,816	$1,340,769	$1,530,274	$1,379,360
Properties	$0	$0	$0	$0
Non Current Deferred Revenue	-	-	$0	$1,865,873
Current Deferred Revenue	-	-	$0	$1,978,660
Other Properties	-	-	$2,056	$6,164

Fetched: 2026-02-02

Cash Flow Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow
Free Cash Flow	$-12,659,802	$-10,753,659	$-15,657,494	$-5,724,246
Operating Activities
Operating Cash Flow	$-12,567,288	$-10,544,870	$-15,292,297	$-5,581,022
Cash Flow From Continuing Operating Activities	$-12,567,288	$-10,544,870	$-15,292,297	$-5,581,022
Operating Gains Losses	$38,364	$-7,972,511	$-15,935,325	$4,246,528
Investing Activities
Capital Expenditure	$-92,514	$-208,789	$-365,197	$-143,224
Investing Cash Flow	$-92,514	$-208,789	$-310,197	$-143,224
Cash Flow From Continuing Investing Activities	$-92,514	$-208,789	$-310,197	$-143,224
Financing Activities
Issuance Of Capital Stock	$819,635	$4,186,862	$3,369,877	$285,108
Financing Cash Flow	$11,464,634	$8,520,376	$18,653,214	$6,525,138
Cash Flow From Continuing Financing Activities	$11,464,634	$8,520,376	$18,653,214	$6,525,138
Net Other Financing Charges	$-439,448	$-793,746	$-908,602	$-21,160
Net Common Stock Issuance	$819,635	$4,186,862	$3,369,877	$285,108
Common Stock Issuance	$819,635	$4,186,862	$3,369,877	$285,108
Other
Repayment Of Debt	$0	$0	$-2,632,324	$-122,469
Issuance Of Debt	$0	$0	$18,110	$6,383,659
End Cash Position	$1,215,640	$2,462,609	$4,808,060	$1,566,688
Beginning Cash Position	$2,462,609	$4,808,060	$1,566,688	$748,015
Effect Of Exchange Rate Changes	$-51,801	$-112,168	$190,652	$17,781
Changes In Cash	$-1,195,168	$-2,233,283	$3,050,720	$800,892
Proceeds From Stock Option Exercised	$11,084,447	$5,127,260	$18,806,153	$0
Net Issuance Payments Of Debt	$0	$0	$-2,614,214	$6,261,190
Net Long Term Debt Issuance	$0	$0	$-2,614,214	$6,261,190
Long Term Debt Payments	$0	$0	$-2,632,324	$-122,469
Long Term Debt Issuance	$0	$0	$18,110	$6,383,659
Net Intangibles Purchase And Sale	$-28,914	$-98,436	$-124,485	$-123,191
Purchase Of Intangibles	$-28,914	$-98,436	$-124,485	$-123,191
Net PPE Purchase And Sale	$-63,600	$-110,353	$-185,712	$-20,033
Sale Of PPE	$0	$0	$55,000	$0
Purchase Of PPE	$-63,600	$-110,353	$-240,712	$-20,033
Change In Working Capital	$-2,026,818	$1,539,714	$-6,704,967	$-232,079
Change In Other Current Liabilities	$-301,674	$-323,711	$-762,150	-
Change In Other Current Assets	$207,953	$189,505	$196,577	-
Change In Payables And Accrued Expense	$-612,409	$2,272,782	$-1,944,557	$2,338,197
Change In Prepaid Assets	$-1,712,310	$-1,275,269	$-37,503	-
Change In Receivables	$391,622	$676,407	$-312,801	$-591,617
Stock Based Compensation	$1,013,788	$444,459	$1,123,250	$0
Asset Impairment Charge	$127,139	$0	$0	-
Depreciation Amortization Depletion	$434,269	$633,008	$769,596	$1,025,058
Depreciation And Amortization	$434,269	$633,008	$769,596	$1,025,058
Amortization Cash Flow	$50,682	$36,282	$55,046	$63,451
Amortization Of Intangibles	$50,682	$36,282	$55,046	$63,451
Depreciation	$383,587	$596,726	$714,550	$961,607
Gain Loss On Investment Securities	$-13,437	$-8,052,581	$-16,064,945	$4,181,545
Net Foreign Currency Exchange Gain Loss	$51,801	$80,070	$120,974	$64,983
Gain Loss On Sale Of PPE	$0	$0	$8,646	$0
Net Income From Continuing Operations	$-12,154,030	$-5,906,953	$-1,313,601	$-14,983,467
Other Non Cash Items	-	$717,413	$6,768,750	$3,438,515
Taxes Refund Paid	-	-	$1,407,199	$1,179,043
Interest Received Cfo	-	-	$2,208	$33
Interest Paid Cfo	-	-	$-289,912	$-254,653
Change In Other Working Capital	-	-	$-3,844,533	$-1,978,659
Change In Payable	-	-	$-1,944,557	$2,338,197

Fetched: 2026-02-02